The companies will invest up to $1 billion over five years to support discovery and development powered by artificial ...

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry challenges like the "patent cliff" and high clinical failure rates. AI-driven ...

This Research Topic is part of the Insights in Experimental Pharmacology and Drug Discovery series. You can explore the ...

In the rapidly evolving world of biotechnology and pharmaceuticals, innovation is the key to staying ahead. One of the most groundbreaking developments in recent years is the alliance between BenchSci ...

Laboratories turned to a smart workaround when COVID‑19 testing kits became scarce in 2020. They mixed samples from several ...

Artificial intelligence (AI) is rapidly transforming industries, and the pharmaceutical sector is poised to be one of its most significant beneficiaries, reshaping how drugs are discovered, tested, ...

Lilly and NVIDIA launch AI co-innovation lab to tackle drug discovery challenges. NVIDIA collaborates with Thermo Fisher to build autonomous lab infrastructure for scalable scientific discovery. Chai ...

Hello, and welcome to a health podocy. I'm your host, Rob Lott. Friends, it's another very special episode of the podcast where we look beyond the authors of specific health affairs articles and ...

A free two-day event in Cambridge will unite experts to discuss translational advances in cell and gene therapy, spanning rare diseases, cancer immunotherapy, and genome editing.

Explore key identity management challenges in pharma and biotech SaaS platforms and learn practical solutions for security, ...